A Study to Investigate the Effect of Administration of Ceftazidime-avibactam (CAZ-AVI) and Ceftaroline Fosamil -Avibactam (CXL) on the Intestinal Flora of Healthy Volunteers

Clinical trial NCT01789528 · COMPLETED

Trial details

NCT number: NCT01789528
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics Open Label CAZ-AVI CXL Effect on Intestinal Flora Safety

Start date: 2013-08-01
Primary completion: 2014-03-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.